Remote GLP-1 & Substance Use Research Study
Researchers at the University of Michigan are conducting a study on substance use patterns and emerging trends, like taking GLP-1 medications, among adults in the United States.
Fast Facts
Have been prescribed a GLP-1 (e.g., Wegovy, Ozempic, Mounjaro, Zepbound)
Regularly use substances (e.g., alcohol, cannabis)
Compensation
provided up to $390
Conducted remotely
Study Background
This study aims to better understand how people use multiple substances and how new trends, like GLP-1 medications, may be shaping those patterns.
Substance use continues to evolve over time, with new combinations of substances and medications becoming more common. Researchers are working to better understand how individuals use substances together, how these patterns change, and what factors may influence them. Emerging trends, such as the use of GLP-1 medications like Ozempic or Wegovy, are an important part of this changing landscape.
By participating in this study, individuals can help researchers gain deeper insight into real-world experiences with substance use. This information may support future public health efforts, improve understanding of substance use behaviors, and help inform strategies to better support individuals and communities.
Study Background
This study aims to better understand how people use multiple substances and how new trends, like GLP-1 medications, may be shaping those patterns.
Substance use continues to evolve over time, with new combinations of substances and medications becoming more common. Researchers are working to better understand how individuals use substances together, how these patterns change, and what factors may influence them. Emerging trends, such as the use of GLP-1 medications like Ozempic or Wegovy, are an important part of this changing landscape.
By participating in this study, individuals can help researchers gain deeper insight into real-world experiences with substance use. This information may support future public health efforts, improve understanding of substance use behaviors, and help inform strategies to better support individuals and communities.
Additional Information
This study is being conducted to better understand patterns of substance use and how emerging trends, including GLP-1 medications, may influence those patterns over time.
You may be eligible for this study if you meet the following criteria.
Inclusion Criteria:
- Regularly use substances (e.g., alcohol, cannabis)
- Have been prescribed a GLP-1 (e.g., Wegovy, Ozempic, Mounjaro, Zepbound)
- Access to a phone for surveys and interviews as part of this study
- Ages 18-75
- Speak English
Participation takes place over one year and is fully remote. Here’s what to expect:
- Complete an initial survey online (phone or computer)
- Participate in a phone interview with study staff
- Complete brief weekly phone interviews for 4 weeks
- Take part in follow-up surveys and interviews at approximately 4, 8, and 12 months
All activities are conducted remotely by phone or online.
Participants may earn up to $390 over the course of the one-year study. Since all activities are completed remotely, no travel is required.
There is no cost for you to participate in our research study.